Literature DB >> 6449924

Observations on Alcaligenes faecalis infection in turkeys.

Y M Saif, P D Moorhead, R N Dearth, D J Jackwood.   

Abstract

Experiments were initiated to study the pathogenicity of 5 Alcaligenes faecalis isolates in specific-pathogen-free poults. The isolates were recovered from commercial flocks suffering from a respiratory disease. There were no differences between cultural or biochemical characteristics of the isolates, but differences in antibiotic sensitivity were detected. All 5 isolates were capable of initiating a respiratory disease in poults similar to that seen in the early stages of turkey coryza. The infection, clinical signs, and lesions were limited to the upper part of the respiratory tract, but there were substantial differences in the severity of disease initiated by different isolates. There were also differences in the persistence of infection in the host. Secondary infections in the tracheas and sinuses were higher in poults infected with A. faecalis. The disease observed in the experimentally infected birds was milder than in 4 naturally infected flocks that also had complicating Escherichia coli infections. There was no evidence of infection with infectious bursal disease virus in 4 naturally occurring outbreaks in Ohio. It is proposed that the term turkey coryza be used to describe the disease initiated by A. faecalis.

Entities:  

Mesh:

Year:  1980        PMID: 6449924

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  13 in total

1.  A role for lipopolysaccharide in turkey tracheal colonization by Bordetella avium as demonstrated in vivo and in vitro.

Authors:  P A Spears; L M Temple; P E Orndorff
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

2.  Soil bacterial consortia and previous exposure enhance the biodegradation of sulfonamides from pig manure.

Authors:  Marina Islas-Espinoza; Brian J Reid; Margaret Wexler; Philip L Bond
Journal:  Microb Ecol       Date:  2012-07       Impact factor: 4.552

3.  Identification and characterization of two Bordetella avium gene products required for hemagglutination.

Authors:  Louise M Temple; David M Miyamoto; Manju Mehta; Christian M Capitini; Stephen Von Stetina; H John Barnes; Vern L Christensen; John R Horton; Patricia A Spears; Paul E Orndorff
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

4.  Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates.

Authors:  J E Mortensen; A Brumbach; T R Shryock
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

5.  Genetic characterization of wild-type and mutant fur genes of Bordetella avium.

Authors:  E R Murphy; A Dickenson; K T Militello; T D Connell
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Unexpected similarities between Bordetella avium and other pathogenic Bordetellae.

Authors:  Patricia A Spears; Louise M Temple; David M Miyamoto; Duncan J Maskell; Paul E Orndorff
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  The Bordetella avium BAV1965-1962 fimbrial locus is regulated by temperature and produces fimbriae involved in adherence to turkey tracheal tissue.

Authors:  Stewart B Loker; Louise M Temple; Andrew Preston
Journal:  Infect Immun       Date:  2011-04-04       Impact factor: 3.441

8.  Characterization of the outer membrane proteins of Bordetella avium.

Authors:  R Leyh; R W Griffith
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Pathogenesis of change in the upper respiratory tracts of turkeys experimentally infected with an Alcaligenes faecalis isolate.

Authors:  J G Gray; J F Roberts; R C Dillman; D G Simmons
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  Isolation and characterization of Bordetella avium phase variants.

Authors:  C R Gentry-Weeks; D L Provence; J M Keith; R Curtiss
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.